Evidence map›Paper›PMID 26833328›Full record

ArticleAmerican journal of human genetics2016

De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations.

Margot R F Reijnders, Vasilios Zachariadis, Brooke Latour, Lachlan Jolly, Grazia M Mancini, Rolph Pfundt, Ka Man Wu, Conny M A van Ravenswaaij-Arts, Hermine E Veenstra-Knol, Britt-Marie M Anderlid and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Case Report:Frontiers in cardiovascular medicine · 2026
    Article
  8. Article
  9. Decreased METTL3 in atrial myocytes promotes atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Ubiquitin system mutations in neurological diseases.Trends in biochemical sciences · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 18 institutions in 6 countries.

Margot R F ReijndersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Vasilios ZachariadisDepartment of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden.
Brooke LatourDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Lachlan JollyNeurogenetics, School of Medicine and the Robinson Research Institute, the University of Adelaide, Adelaide, SA 5005, Australia.
Grazia M ManciniDepartment of Clinical Genetics, Erasmus MC, Sophia Children's Hospital, 3000 CA Rotterdam, the Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Ka Man WuDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Conny M A van Ravenswaaij-ArtsDepartment of Genetics, University of Groningen, University Medical Center of Groningen, 9700 RB Groningen, the Netherlands.
Hermine E Veenstra-KnolDepartment of Genetics, University of Groningen, University Medical Center of Groningen, 9700 RB Groningen, the Netherlands.
Britt-Marie M AnderlidDepartment of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Stephen A WoodThe Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
Sau Wai CheungDepartment of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Angela BarnicoatGreat Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Frank ProbstDepartment of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Pilar MagoulasDepartment of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Alice S BrooksDepartment of Clinical Genetics, Erasmus MC, Sophia Children's Hospital, 3000 CA Rotterdam, the Netherlands.
Helena MalmgrenDepartment of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Arja Harila-SaariDepartment of Women's and Children's Health, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Carlo M MarcelisDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Maaike VreeburgDepartment of Clinical Genetics, Maastricht University Medical Center, 6202 AZ Maastricht, the Netherlands.
Emma HobsonDepartment of Clinical Genetics, Chapel Allerton Hospital, Leeds LS7 4SA, UK.
V Reid SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Zornitza StarkVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
Julie VogtWest Midlands Regional Genetics Service, Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
Nicola CooperClinical Genetics Unit, Birmingham Women's NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2G, UK.
Jiin Ying LimKK Women's and Children's Hospital, 229899 Singapore, Singapore.
Sue PriceDepartment of Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Angeline Hwei Meeng LaiKK Women's and Children's Hospital, 229899 Singapore, Singapore.
Deepti DomingoSchool of Biological Sciences, The University of Adelaide, Adelaide 5000, Australia.
Bruno ReversadeInstitute of Medical Biology, A(∗)STAR, 138648 Singapore, Singapore; Amsterdam Reproduction & Development, Academic Medical Centre & VU University Medical Center, Reproductive Biology Laboratory (Q3-119), Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
DDD Study
Jozef GeczNeurogenetics, School of Medicine and the Robinson Research Institute, the University of Adelaide, Adelaide, SA 5005, Australia.
Christian GilissenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, 6202 AZ Maastricht, the Netherlands.
Usha KiniDepartment of Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Ronald RoepmanDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands. Electronic address: ronald.roepman@radboudumc.nl.
Ann NordgrenDepartment of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands. Electronic address: tjitske.kleefstra@radboudumc.nl.
Radboud University Nijmegen · NLBaylor College of Medicine · USKarolinska University Hospital · SERadboud University Medical Center · NLUniversity of Adelaide · AUErasmus MC - Sophia Children’s Hospital · NLKK Women's and Children's Hospital · SGOxford University Hospitals NHS Trust · GBUniversity Medical Center Groningen · NLAgency for Science, Technology and Research · SGBirmingham Women’s and Children’s NHS Foundation Trust · GBBirmingham Women's Hospital · GBChapel Allerton Hospital · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBGriffith University · AUKarolinska Institutet · SEUniversity Medical Center · USVictorian Clinical Genetics Services · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in more than a hundred genes have been reported to cause X-linked recessive intellectual disability (ID) mainly in males. In contrast, the number of identified X-linked genes in which de novo mutations specifically cause ID in females is limited. Here, we report 17 females with de novo loss-of-function mutations in USP9X, encoding a highly conserved deubiquitinating enzyme. The females in our study have a specific phenotype that includes ID/developmental delay (DD), characteristic facial features, short stature, and distinct congenital malformations comprising choanal atresia, anal abnormalities, post-axial polydactyly, heart defects, hypomastia, cleft palate/bifid uvula, progressive scoliosis, and structural brain abnormalities. Four females from our cohort were identified by targeted genetic testing because their phenotype was suggestive for USP9X mutations. In several females, pigment changes along Blaschko lines and body asymmetry were observed, which is probably related to differential (escape from) X-inactivation between tissues. Expression studies on both mRNA and protein level in affected-female-derived fibroblasts showed significant reduction of USP9X level, confirming the loss-of-function effect of the identified mutations. Given that some features of affected females are also reported in known ciliopathy syndromes, we examined the role of USP9X in the primary cilium and found that endogenous USP9X localizes along the length of the ciliary axoneme, indicating that its loss of function could indeed disrupt cilium-regulated processes. Absence of dysregulated ciliary parameters in affected female-derived fibroblasts, however, points toward spatiotemporal specificity of ciliary USP9X (dys-)function.

Indexed as

MutationAdolescentBase SequenceChildChild, PreschoolChoanal AtresiaDevelopmental DisabilitiesFemaleGenes, X-LinkedGenetic TestingHumansIntellectual DisabilityMolecular Sequence DataPhenotypeUbiquitin ThiolesteraseX Chromosome InactivationUbiquitin ThiolesteraseUSP9X protein, human

Identifiers

PMID26833328
PMCPMC4746365
OpenAlexW2258758898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.